Cellectar Biosciences Inc. (CLRB)

Business: Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer.

IPO Date: 10-Nov-2005

Pres, CEO & Director: Mr. James V. Caruso

Chief Operating Officer: Mr. Jarrod Longcor

Listing: NASDAQ: CLRB

Country: United States

Headquarters: Florham Park, NJ

Website: https://www.cellectar.com

Market cap: $25.15 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-23.90 Mln

Cash: $30.63 Mln

Total Debt: $0.27 Mln

Insider's Holding: 7.35%

Liquidity: Low

52 Week range: $0.34 - 1.32

Shares outstanding: 61,101,300

10 Years Aggregate:

• CFO: $-111.73 Mln
• EBITDA: $-122.53 Mln
• Net Profit: $-119.47 Mln